Skip to content
Research Article Open access CC BY 3.0

Leukemia Therapy: Mechanisms of Drug Resistance and Investigational Strategies

Ami K. Patel, Mei Zhang, Xudong Huang

Journal of Advances in Medicine and Medical Research · pp. 4134–4153 · Published 29 May 2014

10.9734/BJMMR/2014/10235

Abstract

Certain types of leukemia are amongst the first neoplasias to be “cured” with relatively high 5-year remission rates. This is largely due to targeted therapeutics. However, considerable resistance to tumor-specific targeting drugs has developed due to the presence of abundant cancer stem cells, profound genetic diversity, redundant growth/survival pathways and residual disease. Although these issues propose a challenge, they also provide the opportunity for novel innovations of therapy which currently include the development of multi-target kinase inhibitors, multiple drugs acting on multiple targets, key upstream targets covering multiple downstream targets and the future direction of hybrid molecules targeting two or more targets in different pathways.

Leukemia targeted therapeutics drug resistance novel therapies multi-target kinase inhibitors hybrid molecules.

Cited by 1

An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia

Lisa Repsold, Roger Pool, Mohammed Karodia · Cancer Cell International · 2017

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.